Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
Status:
Completed
Trial end date:
2018-07-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Aflibercept (Eylea) is effective in the
treatment of choroidal neovascularization and fibrovascular proliferation in patients with
pseudoxanthoma elasticum (PXE) in terms of preservation or improvement of visual acuity.